RIPK1 and neoplasm: Cellular RIPK1-caspase-8-dependent apoptosis was enhanced by the use of SIRT1 inhibitors, suggesting that RIPK1 may promote apoptosis upon acetylation, thus affecting the biological behavior of tumor cells and influencing tumor development [134].